MedTrace Logo

Laparoscopic Surgery and Abdominal Compliance

NCT02816567 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-07-18

No results posted yet for this study

Summary

The objective of the study is to describe factors influencing abdominal compliance during laparoscopic surgery, including neuromuscular blocking agents (NMBA). The use of NMBA is randomized and blinded from the surgeons and the anesthesiologist. The abdominal compliance is measured by pressure/volume relationship.

Conditions

  • Patients Ongoing Elective Abdominal Laparoscopy

Interventions

DRUG

propofol

DRUG

NMBA - cisatracurium

DRUG

placebo - isotonic saline serum

DRUG

sufentanil

PROCEDURE

laparoscopic surgery

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816567 on ClinicalTrials.gov